Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from High Tide ( (TSE:HITI) ).
High Tide has welcomed a historic U.S. Executive Order that advances the rescheduling of cannabis and paves the way for a federal pilot program under which certain Medicare beneficiaries could receive CBD treatments at no cost, a move the company says underscores growing bipartisan support for more pragmatic cannabis and CBD policies. In response, High Tide is assessing a licensing-based entry for its flagship Canna Cabana retail brand into the U.S., while NuLeaf Naturals and FAB CBD are developing product lines tailored to potential Medicare Advantage supplemental benefits, leveraging their CGMP-certified, THC-free and broad-spectrum offerings to position for leadership in a Medicare-aligned CBD category. The company also disclosed that it has reengaged IR Agency to enhance investor relations and market communications, aiming to better connect with existing and prospective shareholders as it pursues long-term growth across both federally compliant CBD wellness and regulated cannabis markets.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on TSE:HITI Stock
According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.
High Tide’s stock score is primarily influenced by its strong financial performance, particularly in revenue growth and cash flow generation. However, the bearish technical indicators and negative valuation metrics significantly weigh down the overall score. The lack of earnings call data and corporate events further limits the assessment.
To see Spark’s full report on TSE:HITI stock, click here.
More about High Tide
High Tide Inc. is a Calgary-based, retail-focused cannabis company with fully integrated operations spanning the cannabis value chain. Through its wholly owned subsidiary Canna Cabana, it operates one of the world’s largest cannabis retail brands, including the largest bricks-and-mortar cannabis store network in Canada, and also owns prominent U.S. hemp-derived CBD brands such as NuLeaf Naturals and FAB CBD, serving a large direct-to-consumer customer base across multiple jurisdictions.
Average Trading Volume: 107,982
Technical Sentiment Signal: Buy
Current Market Cap: C$346.7M
See more data about HITI stock on TipRanks’ Stock Analysis page.

